PHYSIONEAL 40 Glucose 1.36% w/v Peritoneal Dialysis Solution Twin Bag Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

physioneal 40 glucose 1.36% w/v peritoneal dialysis solution twin bag

vantive pty ltd - glucose monohydrate, quantity: 15 g/l; calcium chloride dihydrate, quantity: 0.184 g/l; magnesium chloride hexahydrate, quantity: 51 mg/l; sodium chloride, quantity: 5.38 g/l; sodium bicarbonate, quantity: 2.1 g/l; sodium lactate, quantity: 1.68 g/l - solution, irrigation - excipient ingredients: water for injections - physioneal 40 is indicated for use in peritoneal dialysis in patients with acute or chronic renal failure.

PHYSIONEAL 40 Glucose 3.86% w/v Peritoneal Dialysis Solution Bag Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

physioneal 40 glucose 3.86% w/v peritoneal dialysis solution bag

vantive pty ltd - glucose monohydrate, quantity: 42.5 g/l (equivalent: glucose, qty 38.6 g/l); sodium chloride, quantity: 5.38 g/l; magnesium chloride hexahydrate, quantity: 51 mg/l; calcium chloride dihydrate, quantity: 0.184 g/l; sodium bicarbonate, quantity: 2.1 g/l; sodium lactate, quantity: 1.68 g/l - solution, dialysis - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - physioneal 40 is indicated for use in peritoneal dialysis in patients with acute or chronic renal failure.

PHYSIONEAL 40 Glucose 2.27% w/v Peritoneal Dialysis Solution Bag Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

physioneal 40 glucose 2.27% w/v peritoneal dialysis solution bag

vantive pty ltd - sodium bicarbonate, quantity: 2.1 g/l; sodium lactate, quantity: 1.68 g/l; magnesium chloride hexahydrate, quantity: 51 mg/l; glucose monohydrate, quantity: 25 g/l (equivalent: glucose, qty 22.7 g/l); calcium chloride dihydrate, quantity: 0.184 g/l; sodium chloride, quantity: 5.38 g/l - solution, dialysis - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - physioneal 40 is indicated for use in peritoneal dialysis in patients with acute or chronic renal failure.

PHYSIONEAL 40 Glucose 1.36% w/v Peritoneal Dialysis Solution Bag Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

physioneal 40 glucose 1.36% w/v peritoneal dialysis solution bag

vantive pty ltd - glucose monohydrate, quantity: 15 g/l (equivalent: glucose, qty 13.6 g/l); sodium bicarbonate, quantity: 2.1 g/l; sodium chloride, quantity: 5.38 g/l; magnesium chloride hexahydrate, quantity: 51 mg/l; sodium lactate, quantity: 1.68 g/l; calcium chloride dihydrate, quantity: 0.184 g/l - solution, dialysis - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - physioneal 40 is indicated for use in peritoneal dialysis in patients with acute or chronic renal failure.

DIANEAL PD-2 Peritoneal Dialysis with 4.25% w/v Glucose Solution Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

dianeal pd-2 peritoneal dialysis with 4.25% w/v glucose solution

baxter healthcare pty ltd - glucose monohydrate, quantity: 4.25 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 257 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis and/or automated peritoneal dialysis and can also be used for acute renal failure.

DIANEAL PD-2 Peritoneal Dialysis with 2.5% w/v Glucose Solution Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

dianeal pd-2 peritoneal dialysis with 2.5% w/v glucose solution

baxter healthcare pty ltd - glucose monohydrate, quantity: 25 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 257 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code),dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis and/or automated peritoneal dialysis and can also be used for acute renal failure.

DIANEAL PD-2 Peritoneal Dialysis with 1.5% w/v Glucose Solution Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

dianeal pd-2 peritoneal dialysis with 1.5% w/v glucose solution

baxter healthcare pty ltd - glucose monohydrate, quantity: 15 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 257 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code),dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis and/or automated peritoneal dialysis and can also be used for acute renal failure.

DIANEAL PD-2 Peritoneal Dialysis with 0.55% w/v Glucose Solution Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

dianeal pd-2 peritoneal dialysis with 0.55% w/v glucose solution

baxter healthcare pty ltd - glucose monohydrate, quantity: 5.5 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 257 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis and/or automated peritoneal dialysis and can also be used for acute renal failure.

Nutrineal Solution for Peritoneal Dialysis 4 with 1.1% Amino Acids Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

nutrineal solution for peritoneal dialysis 4 with 1.1% amino acids

baxter healthcare limited - sodium chloride; l-histidine; l-tryptophan; l-arginine; l-valine; l-tyrosine; sodium (s)-lactate solution; l-lysine hydrochloride; l-leucine; l-isoleucine; l-proline; glycine; l-phenylalanine; l-threonine; l-serine; l-methionine; l-alanine; magnesium chloride; calcium chloride - solution for peritoneal dialysis - 1.1 percent - hypertonic solutions

OXYTOCIN GH Solution for Injection 10 IU/1 mL ampoule Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

oxytocin gh solution for injection 10 iu/1 ml ampoule

generic health pty ltd - oxytocin, quantity: 10 iu/ml - injection, solution - excipient ingredients: sodium chloride; glacial acetic acid; sodium acetate; water for injections - induction of labour; inadequate uterine effort; management of third stage of labour; post-partum haemorrhage.